Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Effect of picibabil (OK432) on neutrophil-mediated anti-tumor activity: Implication of monocyte-derived neutophil activating factors

Effect of picibabil (OK432) on neutrophil-mediated anti-tumor activity: Implication of monocyte-derived neutophil activating factors. Cancer Immunother. 1992; 35:277-82.


Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.